Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Perform…

FromJAMA Pediatrics Editors' Summary


Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Perform…

FromJAMA Pediatrics Editors' Summary

ratings:
Length:
13 minutes
Released:
Dec 3, 2018
Format:
Podcast episode

Description

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Network Open, for the December 3, 2018 issue
Released:
Dec 3, 2018
Format:
Podcast episode

Titles in the series (85)

Editor's Audio Summary for JAMA Pediatrics, from the JAMA Network. On research in medicine, science, and clinical practice related to children’s health and illness